Advertisement

Topics

Novartis Plans To Pay $2.1 Billion For U.S. Company Developing New Prostate Cancer Treatment

08:49 EDT 19 Oct 2018 | Kaiser Health News

With the purchase, the Swiss company is adding to its arsenal of radiopharmaceuticals, a new group of drugs designed to more closely target cancer cells.

Original Article: Novartis Plans To Pay $2.1 Billion For U.S. Company Developing New Prostate Cancer Treatment

NEXT ARTICLE

More From BioPortfolio on "Novartis Plans To Pay $2.1 Billion For U.S. Company Developing New Prostate Cancer Treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...